Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2017, Article ID 3685261, 7 pages
https://doi.org/10.1155/2017/3685261
Research Article

Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosis of Invasive Pulmonary Aspergillosis with Nonneutropenic Patients

1Department of Pulmonology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, China
2Department of Microbiology, The Affiliated Hospital of Ningbo University, 247 Renmin Road, Ningbo, Zhejiang 315020, China

Correspondence should be addressed to Zaichun Deng; moc.anis@bzcnoel and Zhongbo Chen; moc.oohay@bzcnoel

Received 8 July 2017; Revised 4 September 2017; Accepted 12 September 2017; Published 13 November 2017

Academic Editor: Alice M. Turner

Copyright © 2017 Qidong Zhuang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Y. Park, S. O. Lee, S. H. Choi et al., “Serum and bronchoalveolar lavage fluid galactomannan assays in patients with pulmonary aspergilloma,” Clinical Infectious Diseases, vol. 52, no. 7, pp. e149–e152, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. H. He, L. Ding, B. Sun, F. Li, and Q. Zhan, “Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study,” Critical Care, vol. 16, no. 4, article R138, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. H. Nguyen, H. Leather, C. J. Clancy et al., “Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant Recipients,” Biology of Blood and Marrow Transplantation, vol. 17, no. 7, pp. 1043–1050, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Cai, W. Ni, C. Wei, and J. Cui, “Diagnostic value of the serum galactomannan and (1, 3)-β-D-glucan assays for invasive pulmonary aspergillosis in non-neutropenic patients,” Internal Medicine, vol. 53, no. 21, pp. 2433–2437, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. Z. Dai, H. Zhao, S. Cai, Y. Lv, and W. Tong, “Invasive pulmonary aspergillosis in non-neutropenic patients with and without underlying disease: a single-centre retrospective analysis of 52 subjects,” Respirology, vol. 18, no. 2, pp. 323–331, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Kojima, U. Tateishi, M. Kami et al., “Chest computed tomography of late invasive aspergillosis after allogeneic hematopoietic stem cell transplantation,” Biology of Blood and Marrow Transplantation, vol. 11, no. 7, pp. 506–511, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Hoenigl, J. Prattes, B. Spiess et al., “Performance of galactomannan, beta-d-glucan, aspergillus lateral-flow device, conventional culture, and pcr tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis,” Journal of Clinical Microbiology, vol. 52, no. 6, pp. 2039–2045, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. Z. Racil, I. Kocmanova, M. Toskova et al., “Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance,” International Journal of Infectious Diseases, vol. 15, no. 12, pp. e874–e881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Maertens, V. Maertens, K. Theunissen et al., “Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases,” Clinical Infectious Diseases, vol. 49, no. 11, pp. 1688–1693, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. B. De Pauw, T. J. Walsh, and J. P. Donnelly, “Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group,” Clinical Infectious Diseases, vol. 46, no. 12, pp. 1813–1821, 2008. View at Publisher · View at Google Scholar
  11. S.-C. Heng, S. C.-A. Chen, C. O. Morrissey et al., “Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies,” DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, vol. 79, no. 3, pp. 322–327, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. J. D'Haese, K. Theunissen, E. Vermeulen et al., “Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: Analytical and clinical validity,” Journal of Clinical Microbiology, vol. 50, no. 4, pp. 1258–1263, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Russo, S. Giuliano, A. Vena et al., “Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: Does galactomannan have a role?” DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, vol. 80, no. 1, pp. 83–86, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Zhang, S. Wang, Z. Wan, R. Li, and J. Yu, “The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay,” BioMed Research International, vol. 2015, Article ID 943691, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Fortún, P. Martín-Dávila, E. Gomez Garcia de la Pedrosa et al., “Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients,” Infection, vol. 72, no. 6, pp. 738–744, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Prattes, H. Flick, F. Prüller et al., “Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases,” American Journal of Respiratory and Critical Care Medicine, vol. 190, no. 8, pp. 922–929, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. L.-Y. Hsu, Y. Ding, J. Phua et al., “Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.,” BMC Infectious Diseases, vol. 10, p. 44, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. X.-B. Zhang, G.-P. Chen, Q.-C. Lin, X. Lin, H.-Y. Zhang, and J.-H. Wang, “Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease,” Medical Mycology, vol. 51, no. 7, pp. 688–695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Zou, L. Tang, and S. Zhao, “Systematic review and meta-analysis of detecting Galactomannan in bronchoalveolar lavage fluid for diagnosing invasive Aspergillosis,” PLoS ONE, vol. 7, no. 8, Article ID e43347, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Meersseman, K. Lagrou, J. Maertens et al., “Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 1, pp. 27–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Prattes, C. Koidl, S. Eigl, R. Krause, and M. Hoenigl, “Bronchoalveolar lavage fluid sample pretreatment with Sputasol® significantly reduces galactomannan levels,” Infection, vol. 70, no. 5, pp. 541–543, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Y. Park, S.-O. Lee, S.-H. Choi et al., “Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis,” Infection, vol. 61, no. 6, pp. 492–498, 2010. View at Publisher · View at Google Scholar · View at Scopus